MS Advanced MasterClass 14 – Module 1
Our most in-depth exploration into the complexities of MS management and treatment, this course is for specialists who want to really hone their expertise and maximise their impact on patient outcomes. If you are a currently prescribing neurologist, a final-year registrar, an experienced MS specialist nurse or allied health professional or a pharmacist working with MS therapies, this course is the next level in learning meets application.
Halifax Hall, Sheffield University Campus
Endcliffe Vale Road
This course is the ultimate in specialism development and requires attendees to have a strong background and experience in MS as a starting point. Ideal for neurologists and healthcare professionals who already have a specialist interest in MS, this course is suited to those who, for example, are currently prescribing or managing patients on disease-modifying treatments (DMTs), are working in a unit that prescribes MS therapies, or are an MS nurse specialist or an allied health professional who has been practicing for at least three years in that role.
Our in-depth and practically-applicable learning tackles specific issues around the management of MS, such as de-risking MS DMTs or tackling the variation in MS care or service access in the UK. Course attendees are already equipped with a strong understanding of MS, including clinical management, patient experience and optimal treatment and service support.
We will apply for CPD accreditation from the Royal College of Physicians for MS Advanced MasterClass 14 and subject to confirmation of accreditation, CPD will be awarded upon completion of Module 2.
The 2019 Advanced MasterClass was approved for 30 category 1 (external) CPD credit(s). Full conditions of approval are listed in our guidelines. 12 External credits may be claimed for an MSc or equivalent activity.
Last updated: 19/05/2021
In-person and virtual attendance
Due to the COVID-19 pandemic, restrictions may still be in place at the time of the MasterClass. Therefore, we may be limited to the number of people allowed in the room. With this in mind, we will be offering delegates the option of attending the MasterClass virtually. However, should you want to attend the MasterClass in person and have the chance to connect with the MasterClass speakers and network with your fellow delegates, please be assured that we will be following all the government safety advice at the time of the meeting with extra safety precautions of our own.
The course is fully funded including a travel allowance for clinicians practising in the UK for both modules. There will be a £100 deposit required to secure your place, this will be invoiced to you upon confirmation. This deposit will be refunded within 30 days of you completing both modules of the course. Failure to attend or if you should cancel less than 8 weeks of the course commencement date this will result in the charge of £100. → Terms & conditions for international delegates
To complete the course delegates must return for Module 2 where they will present their inter-module project/audit to the Academy.
Dates for module 2 to be confirmed
Last Places Remaining
This activity has been supported by sponsorship from Roche Products Ltd, Biogen Idec Ltd and Janssen-Cilag Ltd. The sponsors have had no control over the educational content of this activity.
SpeakersDr Wallace Brownlee
Honorary Academic Director, MS Academy, MS Specialist Neurologist and MS researcher, National Hospital for Neurology and Neurosurgery Dr David Paling
Honorary Strategic Director, MS Academy, Consultant Neurologist, Royal Hallamshire Hospital Joela Mathews
Lead Neuroscience Pharmacist, Barts Health NHS Trust Dr Nikos Evangelou
Clinical Associate Professor in Neurology, University of Nottingham Dr Emma Tallantyre
Clinical Senior Lecturer, Cardiff University Prof David Baker
Professor of Neuroimmonology, Queen Mary University of London Dr John Woolmore
Consultant Neurologist, Queen Elizabeth Hospital in Birmingham Sarah White
Senior MS Clinical Nurse Specialist, St George’s University Hospitals Dr Eli Silber
Consultant Neurologist, King's College Hospital NHS Foundation Trust
Encouraging excellence, developing leaders, inspiring change
MS Academy was established six years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.